Moderna, Inc. Reports Net Income of $79 Million in Q1 2023
Revenue Declines to $1.86 Billion for Moderna in Q1 2023
By USInMinutes
Published - Aug 03, 2023, 11:41 AM ET
Last Updated - Aug 03, 2023, 11:41 AM EDT
Moderna, Inc.(MRNA), a leading biotechno logy company known for its groundbreaking mRNA-based vaccines, has released its unaudited condensed consolidated financial statements for the first quarter of 2023. The report reveals a mixed financial performance, with a notable decline in revenue compared to the previous year. However, the company managed to achieve a net income of $79 million during the same period.
Net Income/Loss
During the first quarter of 2023, Moderna reported a net income of $79 million. This figure represents the profit generated by the company after deducting all expenses, including operating costs, interest, and taxes.
Revenue
